Percutaneous Left Atrial Appendage Closure - Jacqueline Saw, MD

↳ This is a section part of Moment: Percutaneous Left Atrial Appendage Closure

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Open uri20161018 8824 1ob4p6i?1476789843

Summary

A webinar on Percutaneous Left Atrial Appendage Closure presented by Jacqueline Saw, MD

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Target Audience

  • Interventional cardiologist
  • Electrophysiologist
  • Cardiologists
  • General internist and family physicians

Learning Objectives

This webinar is to inform and educate interventional cardiologists and cardiac surgeons on:

  • Epidemiology of atrial fibrillation and stroke risk
  • Left atrial appendage closure: surgical and percutaneous approaches
  • Randomized controlled trial data with WATCHMAN
  • Percutaneous devices for LAA closure
  • Safety and efficacy of LAA closure

Key references:

  • Saw J, Lempereur M. Percutaneous Left Atrial Appendage Closure: Procedural Techniques and Outcomes. JACC Cardiovasc Interv 2014;7(11):1205-1220.
  • Price, MA, Valderrabano. Left Atrial Appendage Closure to prevent strokes in Patients With Atrial Fibrillation. Circulation. 2014;130:202-212.
  • Holmes DR, Reddy VY, Turi ZG, et al., for the PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534–42.
  • Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 2014;64:1–12.
Loading Simple Education